Vaccine protection against the SARS-CoV-2 Omicron variant in macaques

Mostrar otras versiones (1)

The rapid spread of the SARS-CoV-2 Omicron (B.1.1.529) variant, including in highly vaccinated populations, has raised important questions about the efficacy of current vaccines. In this study, we show that the mRNA-based BNT162b2 vaccine and the adenovirus-vector-based Ad26.COV2.S vaccine provide r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrashekar, Abishek, Yu, Jingyou, McMahan, Katherine, Jacob-Dolan, Catherine, Liu, Jinyan, He, Xuan, Hope, David, Anioke, Tochi, Barrett, Julia, Chung, Benjamin, Hachmann, Nicole P., Lifton, Michelle, Miller, Jessica, Powers, Olivia, Sciacca, Michaela, Sellers, Daniel, Siamatu, Mazuba, Surve, Nehalee, VanWyk, Haley, Wan, Huahua, Wu, Cindy, Pessaint, Laurent, Valentin, Daniel, Van Ry, Alex, Muench, Jeanne, Boursiquot, Mona, Cook, Anthony, Velasco, Jason, Teow, Elyse, Boon, Adrianus C.M., Suthar, Mehul S., Jain, Neharika, Martinot, Amanda J., Lewis, Mark G., Andersen, Hanne, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926910/
https://www.ncbi.nlm.nih.gov/pubmed/35427477
http://dx.doi.org/10.1016/j.cell.2022.03.024
Mostrar todas las versiones(2)

Ejemplares similares